Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
4.840
-0.480 (-9.02%)
At close: Oct 5, 2026, 4:00 PM EDT
4.840
0.00 (0.00%)
Pre-market: Oct 6, 2026, 4:00 AM EDT
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$17,500
Profits / Employee
$395,500
Market Cap
41.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | 1 | 100.00% |
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 113 |
| Actinium Pharmaceuticals | 27 |
| Filana Therapeutics | 20 |
| Veru Inc. | 20 |
| Instil Bio | 17 |
| BriaCell Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| NanoViricides | 7 |
IBO News
- 12 days ago - Impact Biomedical Inc trading resumes - TheFly
- 12 days ago - Impact Biomedical Inc trading halted, volatility trading pause - TheFly
- 19 days ago - Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited) - GlobeNewsWire
- 21 days ago - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) - GlobeNewsWire
- 24 days ago - Impact BioMedical announces 1 for 12.62 reverse stock split - TheFly
- 24 days ago - Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd. - GlobeNewsWire
- 1 month ago - Impact BioMedical Quarterly report: Q2 2026 - Filings
- 4 months ago - Impact BioMedical Quarterly report: Q1 2026 - Filings